DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kovacevic KD, Jilma B, Zhu S. et al.
von Willebrand factor predicts mortality in ACS patients treated with potent P2Y12 antagonists and is inhibited by aptamer BT200 ex vivo.
Thromb Haemost 2020;
120 (09) 1282-1290
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.